Subscribe By RSS or Email
Exosomes Shine a Light on Alzheimer’s Disease and CTE

Exosomes Shine a Light on Alzheimer’s Disease and CTE

Concussions are common in recreational and professional sports with an estimated 1.6 million sustained concussion-related injuries per year in the U.S. alone. Since concussions aren’t detectable using X-rays or CT scans, they often go undiagnosed and attempts to prevent them have been difficult. These concussions can lead to far more serious problems like chronic traumatic […]

Discovery Could Lead to Major Breakthrough in Alzheimer’s Disease and Other Brain Disorders

Discovery Could Lead to Major Breakthrough in Alzheimer’s Disease and Other Brain Disorders

Some leading scientists are making strides like never before in research for debilitating and deadly diseases, such as Alzheimer’s Disease (AD), Chronic Traumatic Encephalopathy (CTE) and Traumatic Brain Injury (TBI).  Currently, people afflicted with these conditions have little hope to avert disease progression and, sadly, death.  There is reason for optimism, though, with hundreds of […]

MD Anderson:  Exosomes May Hold Key to Early Detection of Cancer Through Simple Blood Test

MD Anderson: Exosomes May Hold Key to Early Detection of Cancer Through Simple Blood Test

Recent research at The University of Texas MD Anderson Cancer Center suggests that taking exosomes, nano-size extracellular vesicles secreted by nearly all somatic cells and found in body fluids, from the bloodstream could lead to revolutionary diagnostic tests that can identify tumors in the body at a very early stage.  Dr. Raghu Kalluri, chairman and […]

Recent Articles:

OxySure Systems Schedules FY 2013 Financial Results Conference Call

OxySure Systems, Inc. (OTCQB: OXYS), developer of innovative life saving and easy-to-use emergency oxygen solutions utilizing its proprietary oxygen-from-powder technology, has had an impressive year in fiscal 2013. During the first three quarters of the

Premier Biomedical, Inc. and the “Wild West” of Modern Medicine

Many diseases are caused by the presence of specific molecular compounds within the body, such as metastatic cancer cells in many different types of cancer or tau proteins in Alzheimer’s disease. Companies like Seattle Genetics

Treatments for Non-Alcoholic Steatohepatis Making Clinical Strides

There has been a disease steadily filling market headlines recently, and no; it’s not cancer.  It’s fatty liver disease, particularly Non-alcoholic Fatty Liver Disease, or NAFLD, regarded by many as the most common non-communicable liver

Entia Biosciences to Present at Intercoiffure Symposium

Entia Biosciences, Inc. (OTCQB: ERGO), an authority on the clinical effects of oxidative stress and free radical reactions, today announced that it’s Total Nutraceutical Solutions Inc. subsidiary will be sponsoring the Intercoiffure Spring Business Symposium

Exosomes Shine a Light on Alzheimer’s Disease and CTE

Concussions are common in recreational and professional sports with an estimated 1.6 million sustained concussion-related injuries per year in the U.S. alone. Since concussions aren’t detectable using X-rays or CT scans, they often go undiagnosed

OxySure (OXYS) Announces CE Marking; Prepares for European Launch of Model 615

OxySure Systems, Inc. (OTCQB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology, recently announced that it received CE Marking approval for its OxySure

Entia: An Iron-Clad Opportunity in a Billion Dollar Market

Iron is an essential trace metal  used throughout the human body. For example, iron is an essential component in a protein called hemoglobin that’s responsible for carrying oxygen from the lungs to the rest of

CollabRx: Making Sense of the Complex Cancer Market

Cancer is one of the leading causes of death worldwide and the number of people affected by the disease is growing rapidly. In 2012, more than 14.1 million people around the world were newly diagnosed

Athersys CEO Discusses Recent Developments on Canada’s BNN

The biotechnology sector has been quite volatile over the past few months, as evidenced by the iShares NASDAQ Biotechnology Index ETF’s (NASDAQ: IBB) substantial move higher followed by a retracement lower. Athersys Inc. (NASDAQ: ATHX),

OxySure Systems to Expand Awareness at Taglich Brothers Conference

OxySure Systems Inc. (OTC: OXYS), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology, announced that it would be presenting at the Taglich Brothers 11th Annual Small Cap

Leading Companies Being Defined in the Hunt for a NASH Treatment

The race to develop a treatment for Non-Alcoholic Steatohepatitis (NASH) is getting a lot of airtime lately, pointing to the severity of the disease, poor prognosis and desperate need for a treatment.  The space has

Breakthroughs on the Horizon for Chronic Traumatic Encephalopathy and Other Neurodegenerative Disease

The quest to address long-term neurodegenerative problems associated with traumatic brain injury (TBI) and concussions has received plenty of attention recently, in part because of high profile athletes raising awareness and also because of some